Skip to main content
Smart Investors Daily
SD

NASDAQ · SDGR

Schrödinger, Inc.

Healthcare · Medical - Healthcare Information Services

$27.28

Up+$0.89 (+3.37%)

Updated Oct 12, 2026, 5:41 AM

SID Score

6.3/10

Composite research score

Smart Money

—

Institutional and insider signal

Market cap
1.34B
P/E ratio
-7.34
Dividend yield
0.00%
52-week range
$10.95 – $33.78
Volume
2.08M
Avg. volume
1.08M

Price performance · SDGR

SDGR price history

1M range · 20 trading sessions · Daily adjusted prices

Prices through Oct 9, 2026

SDGR closed at $27.28 after 20 trading sessions, up 31.47% for the selected period.

Last close
$27.28
Period change
+31.47%
Period low
$20.75
Period high
$32.60
Daily close
View OHLC price history
SDGR OHLC price history, latest 40 sessions
DateOpenHighLowCloseVolume
Oct 9, 2026$26.61$28.1624$26.37$27.282.08M
Oct 8, 2026$26.79$27.05$25.69$26.393.08M
Oct 7, 2026$27.81$28.4299$26.8701$27.294.56M
Oct 6, 2026$32.985$33.78$28.56$28.905.26M
Oct 5, 2026$30.33$33.09$29.56$32.604.62M
Oct 2, 2026$30.74$31.14$29.28$30.313.05M
Oct 1, 2026$30.77$31.93$30.01$30.465.14M
Sep 30, 2026$30.55$32.45$30.18$31.053.89M
Sep 29, 2026$29.30$30.60$29.04$30.331.86M
Sep 28, 2026$28.47$30.21$28.2001$29.502.13M
Sep 25, 2026$29.60$29.74$27.69$28.851.37M
Sep 24, 2026$28.97$30.24$28.40$29.452.03M
Sep 23, 2026$30.05$31.14$28.32$29.233.07M
Sep 22, 2026$30.13$31.5948$29.69$30.702.58M
Sep 21, 2026$29.43$31.028$29.00$30.242.89M
Sep 18, 2026$29.32$30.22$28.5502$29.025.23M
Sep 17, 2026$24.09$30.41$24.09$30.249.03M
Sep 16, 2026$23.29$24.39$23.02$23.932.8M
Sep 15, 2026$20.78$23.71$20.34$23.253.8M
Sep 14, 2026$19.03$21.40$18.84$20.751.95M

Latest SDGR news

The latest Smart Investors Daily articles mentioning SDGR.

SDGR research

Overview

Company profile and research snapshot.

Company profile

Schrodinger Inc is a healthcare-based software company. Its operating segments are Software and Drug discovery. Through the Software segment, the company is focused on selling software to transform drug discovery across the life sciences industry and customers in materials science industries. In the Drug discovery segment, it is engaged in generating revenue from a portfolio of preclinical and clinical programs, internally and through collaborations. It generates revenue from the sales of software solutions and from research funding and milestone payments from its drug discovery collaborations.

Visit company website

Analyst outlook

Consensus and target data currently published for this company.

Consensus
Buy
Average target
$19.00
Implied upside
—
Analysts
15
SDGR recent ratings
DateFirmRatingTarget
May 14, 2026Morgan StanleyEqual-Weight—
Mar 17, 2026UBSNeutral—
Jan 8, 2026KeybancOverweight—
Jan 8, 2026TD CowenBuy—
Jan 7, 2026UBSNeutral—
Open full forecast

News briefing

No generated briefing is available yet.

Yahoo · Sep 27, 2026

Schrödinger (SDGR) Could Be 29% Below Fair Value Despite A 38% Overvalued View

Schrödinger (SDGR) has drawn fresh attention after recent trading left the share price at US$28.85, with the stock up strongly over the past month and past 3 months. Investors are reassessing what that move reflects. For context, Schrödinger’s recent surge sits on top of a 30-day share price return of 46.45% and a 90-day share price gain of 65.90%. At the same time, the 1-year total shareholder return of 49.48% contrasts with a 5-year total shareholder loss of 46.56%, signalling powerful...

Yahoo · Sep 23, 2026

Schrodinger Stock Has Technical Strength as It Hits New 2-Year Highs

Schrodinger (SDGR) is trading at new 2-year highs. SDGR maintains strong technical momentum with shares up more than 50% over the past year. SDGR maintains a 100% “Buy” technical opinion from Barchart. Analyst sentiment is mixed, with price targets from $17 to $41.17 and high short interest (15.02%). Caution is...

AI research layers

Interpretive context generated from the platform’s current data sources.

No results

AI research layers have not been published yet.